Harini Shandilya

HS

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2022

Harini Shandilya is an author at AstraZeneca (United States) specializing in antibody engineering, oncology, and aggregation propensity.

Publications per year

2022–2024

3

Publications

3